White Papers
-
Citeline Pharma R&D Review 2024: Pleasant Weather Ahead
5/16/2024
The pharma R&D environment continued its warming trend in 2024, with pipeline drugs rising 7.2% to hit a new high of 22,825. Oncology drugs accounted for 38% of all new drug candidates, while neurologicals came in second with a 12.7% share. Pfizer led the pack with 32 new candidates in the pipeline.
-
Driving ROI: The Business Case For A Comprehensive Financial Transformation Solution
5/15/2024
Explore how utilizing comprehensive financial transformation solutions can address budgeting and site payment challenges, drive value across the study lifecycle, and realize operational and business benefits.
-
Deal-Making Volume Slowed In 2023
5/15/2024
This report provides an overview of alliance, merger and acquisition, and financing deal activities across the global biopharma, medical device, and in vitro diagnostics industries in 2023, as reported by Biomedtracker.
-
Planning For High-Performance Hematologic Oncology Clinical Trials
5/7/2024
Running successful clinical trials in hematologic malignancies necessitates a deep comprehension of a swiftly evolving treatment framework that is growing more nuanced, intricate, and patient-centered.
-
Designing For Diversity
5/6/2024
Embracing diversity enhances our understanding of humanity, fostering empathy and a broader perspective on the world's cultures and behaviors.
-
The Digital Workforce In Clinical Operations
5/6/2024
Uncover this general framework for digital transformation — focusing on clinical monitoring processes within the study conduct lifecycle — and how IQVIA AI/ML models harness automation to deliver client value.
-
The Current And Future Landscape In Respiratory Connected Devices
5/6/2024
Gain insight into the dynamic technological revolution unfolding in respiratory function testing, particularly within wearable connected devices.
-
Closing The Gap In Our Understanding Of Sleep Health With DHTs
4/26/2024
This article delves into the current state of sleep assessments in clinical trials, advocates for a broader understanding of sleep, explores opportunities presented by wearable digital health technologies and examines regulatory expectations.
-
Empowering Transformation Through Technology
4/24/2024
By outlining the transformation of clinical data management into data science, this paper highlights the growing responsibility of data managers as stewards of all clinical trial data and its overall quality.
-
Considerations For Plain Language Summaries
4/22/2024
Recent FDA emphasis on plain language underscores a shift towards greater transparency and patient understanding, highlighted in the joint FDA and Office for Human Research Protections (OHRP) draft guidance.